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Introduciion and overview of HA metaboiism 
Serum contains inhibitors of hyaiuronidase, an enzyme that digests hyaluronan (hyaluronic ac-id, HA). Levels of 
this inhibitor are often elevated in patients with cancer, Iiver disease and with certain dermatological disorders. A 
study of this previously uncharacterized inhibitor was undertaken. 
HA is a polysaccharide consisting of disaccharide repeats of D-glucuronic acid and D-N-acetylglucosamine. It is 
a major component of the exrracellular matrix, predominant whenever rapid cell proliferation, Iocomotion and tissue 
repair occurs. Higher concentrations of HA are observed in the vitreous of the human eye (0.1-0.4 mg/g wet 
wei*~_ht), in synoviai joint fluid (3-4 m*"*/ml), and in the matrix produced by the cumulus cells around the oocyte prior 
to ovulation (-0.5 mg/ml). Levels of HA deposition are under exquisite controls that involve HA syntheses. 
hyaluronidases, and probably by the inhibitors for hyaluronidase. 
Hyaluronidases are a _"*roup of enzymes that digest HA. First identification of this enzyme was as a "spreadin*"* 
factor" that facilitates diffusion of drugs into rissue. This enzyme, which has been relative]y neglected until 
recently, has been revealed to play a key roie in fertilization, embryonic deveiopment, wound healin_"_, as well as in 
neoplasia. Hyaluronidases are cate_*~orized accordin_~* their various properties such as pH optima, substrate specificity 
and catalytic mechanisms. Using molecular genetic techniques, it was established that there are six hyaluronidases' 
in the human **~enome. Tesricular hyaluronidase. PH-20 has pH optima at neutral pH and the expression is restricted 
to testis. Plasma hyaluronidase, Hyal-1, can be observed in most tissues in the human body and enzymatic activity is 
exerted only at acid pH. 
Another level of control for HA deposition may be hyaluronidase inhibitors, a group of compounds about which 
little is known. The first study documentin*~* the existence of a circulating inhibitor of hyaluronidase was in 1946, 
foHowed by clinical reports that increased inhibitor leveis occur in the serum of patients with several disorders. 
These inhibitors were reported to be high molecular weight thermolabile glycoproreins requirin_~ magnesium ion for 
fuH activity. Despite the fact that evidence for such inhibitors has been available for over half a century, that they 
have obvious clinical importance, Iittie progress was made for the further characterization of this molecule. In the 
present study, this uncharacterized inhibitor was investigated using newly developed techniques for measuring 
hyaluronidase activity. 
New iechniques to study the inhibitors 
The following techniques provided much useful information on the nature of hyaluronidase 
inhibitors. 
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A. ELISA-like assay 
Previous methods for quantitation of hyaluronidase either lacked sensitivity. were slow and cumbersome, or 
required highly specialized reagents not available in most laboratories. An improved ELISA-like assay was 
developed in which hyaluronidase activity could easily be detected in most biological samples. l~he free carboxy 
groups of HA are biotinylated in a one-step reaction using biotin hydrazide. Standard and unknown samples of 
enzyme are subsequently allowed to react with the HA substrate covalently bound to the wells of 96-well microtiter 
plates. Residual substrate is detected with an avidin-peroxidase color reaction that can be read using a standard 
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ELISA plate reader. This rapid and sensitive technique, 1000 times more sensitive than the commonly used assays, 
facilitates evaluation of hyaluronidase in most biolo_"_ical samples including the conditioned media of cultured cell. 
This assay facilitated the isolation and sequence analysis of the first vertebrate somatic hyaluronidase, human plasma 
hyaluronidase. Hyal-1. By using a standard amount of a defined hyaluronidase prepararion. the procedure was easily 
converted to a rapid assay for hyaluronidase inhibitors. 
B. Reverse HA-substrate gel procedure 
The reverse HA-substrate *"*el procedure was developed to examine hyaluronidase inhibitors. The HA-substrate 
gel procedure requires addition of HA into the gel mixture before polymerization. The gel is stained with Alcian 
blue. Hyaluronidase activity appears as a white clearing on a light blue background. A variation of this technique 
was deveioped; reverse zymography in which the HA-containin~ ~els is incubated in a solution of hyaluronidase. 
Stained bands mark the presence of inhibitors that protect the HA from degradation. Using this procedure, a maJor 
band was observed in serum speciflc for the neutral-active testicular hyaluronidase. 
Hyaiuronidase inhibitors of mammaiian serum 
A study of these uncharacterlzed serum inhibitors of hyaluronidase was undertaken. Activity was measured 
against bovine testicular hyaluronidase using an ELISA-like assay and reverse HA substrate _"*el zymography. The 
predominant inhibitory activity was magnesium-dependent and could be eiiminated by protease or chondroitinase 
digestion and by heat trealment. Kinetics of inhibition was similar against hyaluronidases from tesris and snake and 
bee venom. The inhibitor had no effect on Stl'eptomyces hyaluronidase. indicating that inhibition was not throu_"_h 
protection of the hyaluronan substratc. Rcverse zymography identified a predominant band of l?_O-kDa rehtive 
molecular size, with lwo bands of greater and one of smaller size. The predominant protein was ideutified as 21 
member of the inter a-inhibitor(Ial) family. 
lal is among the ma_jor Kunitz-type plasma protease inhibitors with large molecular sizes ranging from 120 to 
240kDa. lt Inactivates broad ranges of serine proteases. including trypsin and chymotrypsin, neutrophil elastase, 
plasmin, and acrosin. The original structure reported for lczl consist of two heavy chains and one li*~*ht chain c~lled 
bikunin. The three polypeptide chains are covalently linked by a chondroitin-sulfate chain. Further studies verified 
the many _~*enes codin*~* for the heavy chains, divergence in the number and the combination of peptides, 
which makes lal a complex protein family. 
Rapid increase of HA is commonly observed in the serum of during acute stress, such an in shock or with 
septicemia. In this experiment, the level of Inhibitor elevated in the acule models induced by CC11 or IL-1. It could 
be speculated the rapid increase of HA may be caused by the sudden inhibition of circulatin_"* hyalurouidase activity 
by the inhibitors described here. 
Bxpression oi inter cx -{nhibitor (i cx I), a putative hya[uronidase inhibitor, i~ murine skin 
The largest amount of HA (7-8 g per average adult human. -500/0 of the total in the body) resides in skin tissue, 
where it is present in both the dermis (-0.5 mg/g wet tissue) and the epidelTnis (-O I mg/g ¥vet tissue). Change in 
distribution of this putative hyaluronidase inhibitor, Ial, was examined during the murine hair cyscle and during hair 
development in mouse embryos. The expression of la'l was compared with HA and a cell surface HA receptor, 
CD44. 
The level of HA deposition was accelerated in basal layer of epidemlis. papillary dermis, hair follicle cells at e~~rly 
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anagen, and in the dermal papilla at late anagen and catagen. This observation was compared to the localization of 
lal and CD44. The staining for lal was ¥vell matched to that of HA in mesenchymal tissue (papillary dermis, dermal 
papi~la), whereas concordant expression was observed between CD44 and HA in epithelial tissue (basal layer of 
epidermis, hair follicle cells). This inverse pattem of staining was also observed in the study of hair development in 
mouse embryo. Immunoblot analysis and RT-PCR studies demonstrated that the expression of lal was hair cycle 
dependent with the peak at 3 day after depilation and confirmed that all peptide chains of lal were produced in skin. 
I(~l, the hyaluronidase inhibitor described here, may function as a natural defense system by increasing the level of 
HA, which is an important molecule to sustain water in tissue and to prevent further dama*~*e. 
Concluding remarks 
It has been almost 70 years since the first isolation of HA from the vitreous of bovine eyes. The biological 
importance of this molecule has not been recognized until recently, mainly because of the static feature of this 
molecule. Recent progress has caused reevaluation with the demonstration that it is an active molecule. Here, a 
study of the uncharacterized serum inhibitor of hyaluronidase, first described half a century ago, was undertaken. By 
using newly developed techniques, of ELISA-like hyaluronidase assay technique and reverse HA-substrate _"*el 
technique, this inhibitor was identified as a member of the lal, with the molecular mass of 120 kDa. This inhibitor 
was elevated in acute phase models induced by IL-1 and CCll. Ial was co-localized with HA in murine dorsal skin 
during hair cycle and during hair development. These resuhs sug~ested this molecule play an important role in HA 
deposition and in the deterrnining of the size of HA in tissue. 
The biology of HA is now _"*etting into a new phase and our understandin*~* of this molecule will probably make 
major pro_~*ress in the coming decades. In this report, endo_*"enous hyaiuronidase inhibitor, which has been left 
uncharacterized for half a century, was investigated. Afthough there are still many subjects to be investigated, or we 
may be just in front of the entrance door, in understanding the nature of this serum hyaluronidase inhibitor, it has 
potency for clinical applications as well as introducing a new concept in HA metabolism. 
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マ 論文審査の結果の要旨
 生体がストレスを受けた際,ヒアルロン酸は組織中の水分を保持しさらなるダメージを防ぐ重要な機
 能を持つ。
 血清中にはヒアルロン酸を分解するヒアルロニダーゼのインヒビターがある。このインヒビターは,
 ガン患者や肝また皮膚疾患の患者において活性の昂進が認められる。三尾和弘提出の本論文は,これま
 でその実体が明らかになっていなかった当該インヒビターの特徴を明らかにしたものである。
 このインヒビターの存在が最初に報告されたのは1946年にさかのぼる。これらはいくつかの疾病を持
 つ患者の血清中にその発現の亢進がみられることが臨床的にも報告されていた。これらインヒビターは
 高分子の熱に不安定な糖タンパク質であり,マグネシウムイオン要求性であること以外,この50年あま
 りの間,当該の分子に関してさらなる解析は進んでいなかった。本論文は,当該分子の生理学的重要性
 に鑑みて,ヒアルロニダーゼとそのインヒビターの活性測定法を新たに開発することによりその特徴を
 明らかにしょうとしたものである。
 新たに開発した方法は2種類であり,その一つはELIZA様解析手段,他方はリバース・ヒアルロン酸基
 質・ゲル法(ReverseHA-substrategelprocedure)と名付けた方法である。前者はこれまでのヒアルロニダ
 ー ゼ活性測定方法に比べ!000倍の感度を持ち,生体試料の当該活性の検出を容易にする方法である。リ
 バース・ヒアルロン酸基質・ゲル法は電気泳動されたヒアルロニダーゼやそのインヒビターの位置をゲ
 ル上で可視化する技術である。
 この方法を用いて,血清中のヒアルロニダーゼインヒビターが1α1(interα一inhibitor)のメンバーに属
 すること,L!やCC1、によるacutephasemodelにおいてこのインヒビターの活性亢進が認められること,
 これらはストレスを受けた際に認められる血清中のヒアルロン酸の急激な増加に大きく寄与しうること,
 さらには生体のヒアルロン酸の約50%を占める皮膚において,マウスでは毛周期また毛の成長期に1α1が
 ヒアルロン酸とco-locallzeしていることを発見した。本研究は,当該インヒビターが,組織中のヒアルロ
 ン酸の蓄積量等に重要な役割を果たしていることを強く示唆している。
 これらの成果は,本人が自立して研究活動を行うに必要な高度の研究能力と学識を有することを示し
 ている。したがって,三尾和弘提出の論文は,博士(理学)の学位論文として合格と認める。
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